SPARC and prostate cancer: These proteins include MMP-9, which can be used as a biomarker for cancer [120,121,122]; SPARC, an acidic secretory protein rich in cysteine, was positively correlated with CTSK expression and predicted a poor prognosis in prostate cancer and gastric adenocarcinoma [28,95,123].